NeuroPace NPCE
NASDAQ NPCE
$14.50 -0.26 (-1.76%)
As of: Sep 9, 2026 · 3:59 PM EDT

NeuroPace (NPCE) Income from Continuing Operations (2020 - 2026)

NeuroPace (NPCE) posted Income from Continuing Operations of -$6.2 million for Q2 2026, up 5.59% on a QoQ basis from -$6.5 million in Q1 2026, and up 35.37% year-over-year from -$4.5 million in Q2 2025.

Analysis

NeuroPace (NPCE) Income from Continuing Operations (2020 - 2026) Analysis & Trends

NeuroPace has reported Income from Continuing Operations for 7 years, with the latest figure at -$6.2 million in Q2 2026.

  • On a quarterly basis, Income from Continuing Operations rose 35.37% year-over-year to -$6.2 million in Q2 2026; TTM through Jun 2026 was -$19.0 million, a 29.33% increase from a year earlier, with the FY2025 full-year figure at -$21.0 million, up 23.56% from the prior year.
  • Income from Continuing Operations was -$6.2 million for Q2 2026 at NeuroPace, up from -$6.5 million in the prior quarter.
  • The five-year high for Income from Continuing Operations was -$2.7 million in Q4 2025, with the low at -$12.6 million in Q2 2022.
  • Average Income from Continuing Operations over 5 years is -$7.9 million, with a median of -$7.5 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations slumped 101.12% in 2022, then surged 47.15% in 2025.
  • Over 5 years, Income from Continuing Operations stood at -$11.0 million in 2022, then jumped by 41.23% to -$6.5 million in 2023, then grew by 20.12% to -$5.2 million in 2024, then soared by 47.15% to -$2.7 million in 2025, then plunged by 125.69% to -$6.2 million in 2026.
  • The last three Income from Continuing Operations figures came in at -$6.2 million (Q2 2026), -$6.5 million (Q1 2026), and -$2.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 1.48 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -92.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 249.10 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 201.00 Mn
10 NeuroPace 493.15 Mn 441.45 Mn 18.91 Mn -6.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.16 Mn
Mar 31, 2026 -6.52 Mn
Dec 31, 2025 -2.73 Mn
Sep 30, 2025 -3.58 Mn
Jun 30, 2025 -9.53 Mn
Mar 31, 2025 -6.51 Mn
Dec 31, 2024 -5.16 Mn
Sep 30, 2024 -5.67 Mn
Jun 30, 2024 -7.63 Mn
Mar 31, 2024 -8.98 Mn
Dec 31, 2023 -6.47 Mn
Sep 30, 2023 -7.37 Mn
Jun 30, 2023 -9.25 Mn
Mar 31, 2023 -9.56 Mn
Dec 31, 2022 -11.00 Mn
Sep 30, 2022 -11.68 Mn
Jun 30, 2022 -12.61 Mn
Mar 31, 2022 -11.46 Mn
Dec 31, 2021 -10.69 Mn
Sep 30, 2021 -7.93 Mn